Valeo Financial Advisors’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,125
Closed -$59K 644
2021
Q4
$59K Hold
2,125
﹤0.01% 561
2021
Q3
$89K Hold
2,125
0.01% 534
2021
Q2
$99K Sell
2,125
-514
-19% -$25.5K 0.01% 470
2021
Q1
$146K Hold
2,639
0.01% 518
2020
Q4
$192K Hold
2,639
0.01% 428
2020
Q3
$521K Sell
2,639
-29
-1% -$7.3K 0.05% 188
2020
Q2
$747K Sell
2,668
-125
-4% -$29.2K 0.07% 152
2020
Q1
$550K Sell
2,793
-185
-6% -$39.7K 0.06% 164
2019
Q4
$731K Sell
2,978
-36
-1% -$6.63K 0.07% 161
2019
Q3
$355K Sell
3,014
-13,736
-82% -$2.08M 0.04% 209
2019
Q2
$2.71M Hold
16,750
0.31% 53
2019
Q1
$3.96M Buy
16,750
+83
+0.5% +$21K 0.48% 37
2018
Q4
$4.52M Hold
16,667
0.63% 32
2018
Q3
$4.58M Buy
16,667
+16,650
+97,941% +$7.8M 0.62% 32
2018
Q2
$8K Buy
+17
New +$8.99K ﹤0.01% 991
2017
Q4
Sell
-11,843
Closed -$4.96M 1384
2017
Q3
$4.96M Buy
+11,843
New +$3.63M 1.12% 13

Other funds holding ASMB

Valeo Financial Advisors's ASMB Position: Q1 2022 in Review

Valeo Financial Advisors sold out of Assembly Biosciences (ASMB) in Q1 2022, closing a stake of 2,125 shares — an estimated $59K sold.

Valeo Financial Advisors first reported a position in ASMB in Q3 2017 and held it in 16 quarters. The position peaked at $4.96M in Q3 2017. 54 funds tracked by Wall St. Rank hold ASMB as of Q1 2022.

  • Valeo Financial Advisors reported no remaining Assembly Biosciences position as of Q1 2022 after selling out during the quarter.
  • Valeo Financial Advisors sold 2,125 Assembly Biosciences shares in Q1 2022, an estimated $59K.
  • Valeo Financial Advisors first reported a position in Assembly Biosciences in Q3 2017 and held it in 16 quarters.
  • Valeo Financial Advisors's Assembly Biosciences position peaked at $4.96M in Q3 2017.
  • 54 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2022.

Based on Valeo Financial Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.